Neurodiagnostics Market to Reach $18 Billion by 2024 - Key Vendors are Agilent Technologies, Alpha Omega & Hologic - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Neurodiagnostics Market Analysis By Technology, By In Vitro Diagnostics, By Neuroinformatics And Segment Forecasts To 2024" report to their offering.

The global neurodiagnostics market was valued at 13.6 billion in 2015 and is expected to reach a value of USD 18.3 billion by 2024.

Key factors driving the market growth include increasing prevalence of neurological diseases due to demographic changes and growing awareness of their management. In addition, consistent technological modifications coupled with increased preference for novel diagnostic technologies will further fuel the market. The economic burden of neurological diseases is extremely high on society and governments with around 1 billion people suffering globally.

Biomarkers are an important part of in vitro diagnostics for neurological disorders as their development is targeted at the early disease diagnosis with information about nervous system. Although biomarkers are not commercially available in the market, their use is confined to clinical research settings.

Increased life expectancy has resulted in increased geriatric population across the globe. The prevalence of aging-related neurological diseases such as Alzheimer's disease and Parkinson's disease is on the rise. The diagnosis of these diseases includes neuroimaging, in vitro diagnosis, and neuroinformatics.

North America held the major market share of around 36% in the year 2015 and will retain its top position during the forecast period. On the other hand, Asia Pacific will exhibit highest CAGR of 4% over the forecast period.

Companies Mentioned:

  • Agilent Technologies
  • Alpha Omega Ltd.
  • Bruker
  • Doric Lenses, Inc.
  • Fonar Corporation
  • GE Healthcare
  • Guerbet
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • Mightex Systems
  • NeuroNexus Technologies
  • Neusoft Medical Systems Co., Ltd.
  • Philips Healthcare
  • Plexon, Inc.
  • Roche Diagnostics
  • Siemens Healthcare
  • Toshiba Medical Systems Corporation

Key Topics Covered:

1 Methodology & Scope

2 Executive Summary

3 Market Summary

4 Market Variables, Trends& Scope

5 Market Categorization 1: Technology Estimates & Trend Analysis

6 Market Categorization 2: Regional Estimates & Trend Analysis, by Technology

7 Competitive Landscape

For more information about this report visit http://www.researchandmarkets.com/research/995bbd/neurodiagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics